Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Itraconazole for Blastomycosis, Histoplasmosis, and Sporotrichosis
NCT00004811Phase 2Completed
- Sponsor
- National Center for Research Resources
- Start
- Mar 1985
- Modality
- Orthosteric Ligands
01
Overview
Phase 2, open-label, single-arm trial of itraconazole in blastomycosis, histoplasmosis and sporotrichosis, sponsored by National Center for Research Resources. Primary endpoint: Tolerance of patients to different doses of itraconazole at 12 months. Started Mar 1985; status: completed.
02
Drugs
itraconazole
03
Conditions
blastomycosishistoplasmosissporotrichosis
Beyond the preview
Go deeper on NCT00004811.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00004811.